These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 4346144
21. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo. Ekelund U. Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745 [Abstract] [Full Text] [Related]
24. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II. O'Connor GJ, Baranowski RL, Kurtzman NA. Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454 [No Abstract] [Full Text] [Related]
25. Evidence for myocardial conversion of angiotensin I. Gerlings ED, Gilmore JP. Basic Res Cardiol; 1974 May; 69(3):222-7. PubMed ID: 4370010 [No Abstract] [Full Text] [Related]
26. Comparison of iv and ia infusion of vasoactive agents on dog forelimb blood flow. Daugherty RM, Scott JB, Emerson TE, Haddy FJ. Am J Physiol; 1968 Mar; 214(3):611-9. PubMed ID: 4295660 [No Abstract] [Full Text] [Related]
27. Primary and secondary effects of angiotensin on the coronary circulation. Drímal J, Pávek K, Selecký FV. Cardiologia (Basel); 1969 Mar; 54(1):1-15. PubMed ID: 4313476 [No Abstract] [Full Text] [Related]
28. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. Richardson PD, Withrington PG. J Physiol; 1978 Sep; 282():451-70. PubMed ID: 722550 [Abstract] [Full Text] [Related]
29. Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature. Satoh S, Zimmerman BG. Circ Res; 1975 Jun; 36(6 Suppl 1):89-96. PubMed ID: 805674 [Abstract] [Full Text] [Related]
32. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Cousin M, Custaud MA, Baron-Menguy C, Toutain B, Dumont O, Guihot AL, Vessières E, Subra JF, Henrion D, Loufrani L. Hypertension; 2010 Jan; 55(1):109-15. PubMed ID: 19948989 [Abstract] [Full Text] [Related]
33. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance. Abernethy DR, Laurie N, Andrawis NS. Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707 [Abstract] [Full Text] [Related]
37. Decreased vasoconstrictor response to angiotensin II in the presence of vascular stenosis. Stock J, Wolf G. J Clin Pharmacol; 1974 Jan; 14(1):17-24. PubMed ID: 4358347 [No Abstract] [Full Text] [Related]
38. Augmentation of hepatic blood flow by acetylcholine. Wangensteen SL, Ludewig RM, Madden JJ. Am J Surg; 1970 May; 119(5):510-4. PubMed ID: 5441740 [No Abstract] [Full Text] [Related]
39. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Stegbauer J, Oberhauser V, Vonend O, Rump LC. Cardiovasc Res; 2004 Feb 01; 61(2):352-9. PubMed ID: 14736552 [Abstract] [Full Text] [Related]
40. The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog. Richardson PD, Withrington PG. Br J Pharmacol; 1977 Jan 01; 59(1):147-56. PubMed ID: 836995 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]